233 South 10th Street
Suite 609
Philadelphia, PA 19107
(215) 503-9064
Suite 609
Philadelphia, PA 19107
(215) 503-9064
Most Recent Peer-reviewed Publications
- Dynamic regulation of mitochondrial transcription as a mechanism of cellular adaptation
- MYST protein acetyltransferase activity requires active site lysine autoacetylation
- Inhibition of the single downstream target BAG1 activates the latent apoptotic potential of MYC
- Enzymatic assays for assessing histone deubiquitylation activity
- Phosphorylation of Tip60 by GSK-3 Determines the Induction of PUMA and Apoptosis by p53
- Myc overexpression brings out unexpected antiapoptotic effects of miR-34a
- Regulation of microRNA-145 by growth arrest and differentiation
- Deacetylation of the DNA-binding domain regulates p53-mediated apoptosis
- Emerging concepts in the analysis of transcriptional targets of the MYC oncoprotein: Are the targets targetable?
- Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase
- Rise of the rival
- Biochemical pathways that regulate acetyltransferase and deacetylase activity in mammalian cells
- hMOF, a KAT(8) with Many Lives
- Acetylation of the DNA binding domain regulates transcription-independent apoptosis by p53
- Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
- The p53 family and programmed cell death
- Control of nucleotide biosynthesis by the MYC oncoprotein
- USP22, an hSAGA subunit and potential cancer stem cell marker, reverses the polycomb-catalyzed ubiquitylation of histone H2A
- The Putative Cancer Stem Cell Marker USP22 Is a Subunit of the Human SAGA Complex Required for Activated Transcription and Cell-Cycle Progression
- The ARF/oncogene pathway activates p53 acetylation within the DNA binding domain